Insilico Signs Massive $2.5B Partnership with SK Biopharmaceuticals for Neuroimmune Therapies
Insilico Medicine and SK Biopharmaceuticals have announced a strategic global research and development collaboration at the BIO 2026 International Convention. The partnership aims to discover...
Sun Pharma Acquires Checkpoint Therapeutics in ₹2,480 Crore Global Expansion Move
Sun Pharmaceutical Industries Limited, one of the world’s leading pharmaceutical giants, announced a definitive agreement to acquire Checkpoint Therapeutics in a transaction valued at...
Lupin Introduces Azilsartan Medoxomil Tablets in the United States
Lupin Limited (Lupin) the Indian Global pharmaceuticals major announced that the company will launch Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States, which got approval from the U.S. byAbbreviated New Drug Application (ANDA).
This is a bioequivalent product of Edarbi® produces byAzurity Pharmaceuticals,...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
Eli Lilly Acquires 4E Therapeutics to Accelerate Development of Non-Opioid Chronic Pain Treatments
Eli Lilly and Company (Lilly) has successfully acquired 4E Therapeutics, a Texas-based neuroscience company pioneering next-generation treatments for chronic pain. The acquisition integrates 4E...